Herbas VPB

Print
EN | LT
LT - ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER
EN - ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 47/6855 (2017.08)
A61P 35/00 (2006.01)
A61K 47/6857 (2017.08)
A61K 47/6859 (2017.08)
A61K 47/6863 (2017.08)
A61K 47/6865 (2017.08)
A61K 47/6867 (2017.08)
A61K 47/6869 (2017.08)
A61K 47/6803 (2017.08)
A61P 1/00 (2018.01)
A61P 1/02 (2018.01)
A61P 1/16 (2018.01)
A61P 1/18 (2018.01)
A61P 11/00 (2018.01)
A61P 13/08 (2018.01)
A61P 13/12 (2018.01)
A61P 15/00 (2018.01)
A61P 17/00 (2018.01)
A61P 19/00 (2018.01)
A61P 21/00 (2018.01)
A61P 25/00 (2018.01)
A61P 35/00 (2018.01)
A61P 35/02 (2018.01)
A61P 5/14 (2018.01)
European patent
(11) Number of the document 3607996
(13) Kind of document T
(96) European patent application number 19195042.7
Date of filing the European patent application 2015-04-27
(97) Date of publication of the European application 2020-02-12
(45) Date of publication and mention of the grant of the patent 2023-01-04
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
14305621 2014-04-25 EP
Inventors
(72)
RILATT, Ian , FR
PEREZ, Michel , FR
GOETSCH, Liliane , FR
BROUSSAS, Matthieu , FR
BEAU-LARVOR, Charlotte , FR
HAEUW, JEAN-FRANCOIS , FR
LAMOTHE, Marie , FR
Grantee
(73) PIERRE FABRE MEDICAMENT , Les Cauquillous, 81500 Lavaur, FR
Title
(54) ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER
  ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER